Unnamed: 0,title,date,stock,sentiment
1220442.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,TENX,positive
1220443.0,85 Biggest Movers From Yesterday,2020-06-04 05:02:00-04:00,TENX,neutral
1220444.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-06-03 12:18:00-04:00,TENX,neutral
1220445.0,Tenax Therapeutics shares are trading lower on a potential sell-off after the company stock rose roughly 100% yesterday following the Phase 2 trial results for its Levosimendan.,2020-06-03 09:15:00-04:00,TENX,neutral
1220446.0,Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement,2020-06-03 08:35:00-04:00,TENX,neutral
1220447.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,TENX,negative
1220448.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-06-03 07:10:00-04:00,TENX,neutral
1220449.0,72 Biggest Movers From Yesterday,2020-06-03 05:11:00-04:00,TENX,neutral
1220450.0,Ziyad Binsalamah Dissolves Share Stake In Tenax Therapeutics As Of June 2,2020-06-02 16:22:00-04:00,TENX,positive
1220451.0,Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Kaleido Biosciences Shares Plunge,2020-06-02 14:30:00-04:00,TENX,negative
1220452.0,What's Driving Shares of Nano-Cap Pharma Tenax Higher?,2020-06-02 13:07:00-04:00,TENX,positive
1220453.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-06-02 12:21:00-04:00,TENX,neutral
1220454.0,Mid-Day Market Update: NASDAQ Turns Lower; MoneyGram International Shares Jump,2020-06-02 12:10:00-04:00,TENX,neutral
1220455.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,TENX,neutral
1220456.0,Mid-Morning Market Update: Markets Open Higher; Donaldson Reports Mixed Q3 Results,2020-06-02 10:20:00-04:00,TENX,neutral
1220457.0,Tenax Therapeutics shares are trading higher after the company reported results from its Phase 2 trial of Levosimendan. The trial demonstrated a significant reduction in right atrial and pulmonary capillary wedge pressures.,2020-06-02 08:50:00-04:00,TENX,positive
1220458.0,Tenax Therapeutics Reports Results From Phase 2 Trial Of Levosimendan; Demonstrated 'Significant' Reduction In Right Atrial And Pulmonary Capillary Wedge Pressures And Improvement In 6-Min Walk Distance,2020-06-02 07:33:00-04:00,TENX,positive
1220460.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,TENX,positive
1220461.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-28 10:39:00-04:00,TENX,neutral
1220462.0,Tenax Therapeutics 13D From Ziyad Binsalamah Shows 5.1% Stake,2020-05-18 10:37:00-04:00,TENX,neutral
1220464.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-04-13 07:39:00-04:00,TENX,neutral
1220465.0,Tenax Therapeutics Reports Last Patient Completes Final Visit In Phase 2 HELP Study Of Levosimendan For Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction,2020-04-09 08:35:00-04:00,TENX,neutral
1220466.0,Tenax Therapeutics Filing Shows Registration For 750K Common Stock Offering,2020-03-13 08:16:00-04:00,TENX,neutral
1220467.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,TENX,negative
1220468.0,Tenax Therapeutics Reports Completion Of Enrollment In Phase 2 Pulmonary Hypertension Trial,2020-03-12 08:31:00-04:00,TENX,neutral
1220469.0,"Tenax Therapeutics Announces A $2.75M Registered Direct Offering Of 750,000 Shares Priced At $1.16511/Share",2020-03-12 08:18:00-04:00,TENX,positive
1220470.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,TENX,negative
1220472.0,Tenax Therapeutics Expects Full Enrollment In Phase 2 Pulmonary Hypertension Clinical Trial In First Half Of 2020; Says No Serious Drug-related Adverse Events Have Been Reported To Date,2020-01-13 08:44:00-05:00,TENX,negative
1220473.0,Tenax Therapeutics Offers Update On Phase 2 Pulmonary Hypertension Clinical Trial,2019-10-31 08:05:00-04:00,TENX,neutral
1220474.0,Tenax Therapeutics Conducting Double-Blind Placebo Controlled Phase 2 Trial Designed To Evaluate Levosimendan In Patients With Pulmonary Hypertension,2019-08-23 08:02:00-04:00,TENX,neutral
1220475.0,62 Biggest Movers From Friday,2019-04-01 04:46:00-04:00,TENX,neutral
1220476.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mar. 29, 2019",2019-03-29 08:21:00-04:00,TENX,positive
1220477.0,58 Biggest Movers From Yesterday,2019-03-29 06:13:00-04:00,TENX,neutral
1220478.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-03-28 12:50:00-04:00,TENX,neutral
1220479.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Mar. 28, 2019",2019-03-28 09:57:00-04:00,TENX,positive
1220480.0,36 Stocks Moving In Thursday's Pre-Market Session,2019-03-28 08:11:00-04:00,TENX,neutral
1220481.0,48 Stocks Moving In Monday's Mid-Day Session,2019-03-18 12:33:00-04:00,TENX,neutral
1220482.0,24 Stocks Moving In Monday's Pre-Market Session,2019-03-18 08:07:00-04:00,TENX,neutral
1220483.0,Tenax Therapeutics Enrolls its First Patient in the Phase 2 Pulmonary Hypertension Clinical Trial,2019-03-11 08:30:00-04:00,TENX,neutral
1220484.0,30 Stocks Moving In Monday's Pre-Market Session,2019-03-11 08:02:00-04:00,TENX,neutral
1220485.0,"Tonix Pharma, Tenax Therapeutics 13G Filings From Iroquois Capital Show New 9.99% Stake",2018-12-14 15:48:00-05:00,TENX,neutral
1220486.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 11, 2018",2018-12-12 11:47:00-05:00,TENX,negative
1220487.0,"The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel",2018-12-12 08:07:00-05:00,TENX,positive
1220488.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,TENX,neutral
1220489.0,48 Biggest Movers From Friday,2018-12-10 05:23:00-05:00,TENX,neutral
1220490.0,"The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut",2018-12-07 08:04:00-05:00,TENX,neutral
1220491.0,25 Stocks Moving In Friday's Pre-Market Session,2018-12-07 07:54:00-05:00,TENX,neutral
1220492.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,TENX,negative
1220493.0,50 Biggest Movers From Tuesday,2018-12-06 05:17:00-05:00,TENX,neutral
1220494.0,52 Biggest Movers From Friday,2018-12-03 05:42:00-05:00,TENX,neutral
1220495.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018",2018-11-29 10:59:00-05:00,TENX,negative
1220496.0,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",2018-11-29 08:09:00-05:00,TENX,neutral
1220497.0,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",2018-11-27 07:32:00-05:00,TENX,negative
1220498.0,41 Biggest Movers From Yesterday,2018-11-27 05:08:00-05:00,TENX,neutral
1220499.0,"Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018",2018-11-26 10:44:00-05:00,TENX,negative
1220500.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018",2018-11-23 09:09:00-05:00,TENX,negative
1220501.0,50 Biggest Movers From Wednesday,2018-11-23 05:17:00-05:00,TENX,neutral
1220502.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,TENX,negative
1220503.0,Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial,2018-11-19 08:04:00-05:00,TENX,neutral
1220504.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",2018-11-14 08:17:00-05:00,TENX,neutral
1220505.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018",2018-11-08 10:52:00-05:00,TENX,negative
1220506.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,TENX,negative
1220507.0,88 Biggest Movers From Yesterday,2018-11-08 04:54:00-05:00,TENX,neutral
1220508.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-09-20 12:31:00-04:00,TENX,neutral
1220509.0,Tenax Therapeutics Names Anthony DiTonno CFO,2018-06-05 16:31:00-04:00,TENX,neutral
1220510.0,28 Stocks Moving In Monday's Pre-Market Session,2018-06-04 08:11:00-04:00,TENX,neutral
1220511.0,Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients,2018-06-01 08:30:00-04:00,TENX,neutral
1220512.0,"Tenax Shares Up 10%, Just Off Session Highs; Volume Came Into Stock Over Last Few Mins. As Traders Circulate Word Of New Buy Recommendation From Unnamed Newsletter",2018-05-08 10:20:00-04:00,TENX,positive
1220513.0,Finding Breakouts And Avoiding Fakeouts In A Market At War With Itself,2018-04-06 13:36:00-04:00,TENX,negative
1220514.0,"Benzinga's Top Analyst Calls From April 5, 2018",2018-04-05 14:43:00-04:00,TENX,positive
1220515.0,28 Stocks Moving In Thursday's Mid-Day Session,2018-04-05 12:58:00-04:00,TENX,neutral
1220516.0,Ladenburg Thalmann Recommends Acquiring Shares Of Tenax Therapeutics At Current Prices As They Believe The Possible Risk/Reward Of A Positive Phase 2 Outcome Could Offer A Strong Risk/Reward Profile From Current Valuation,2018-04-05 10:13:00-04:00,TENX,positive
1220517.0,Shares of Tenax Spiking Higher As Traders Circulate Chatter That Ladenburg Raised Their Price Target On The Co. To  $15/Share,2018-04-05 10:06:00-04:00,TENX,positive
1220518.0,36 Biggest Movers From Yesterday,2018-04-05 04:40:00-04:00,TENX,neutral
1220519.0,Mid-Afternoon Market Update: Dow Turns Positive; RMG Networks Holding Shares Plummet,2018-04-04 14:33:00-04:00,TENX,positive
1220520.0,Mid-Day Market Update: Cloudera Falls Following Disappointing Outlook; Proteostasis Therapeutics Shares Gain,2018-04-04 13:08:00-04:00,TENX,positive
1220521.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-04-04 12:50:00-04:00,TENX,neutral
1220522.0,Mid-Morning Market Update: Markets Open Lower; Lennar Earnings Top Views,2018-04-04 10:37:00-04:00,TENX,negative
1220523.0,Tenax Therapeutics Reports Results Of Pre-IND Meeting With FDA For Phase 2 Study Of Levosimendan in PH-HFpEF Patients,2018-04-04 08:01:00-04:00,TENX,neutral
1220524.0,Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement,2018-03-14 08:05:00-04:00,TENX,neutral
1220525.0,"BZ NOTE On Tenax Price Action, Chatter: Issue Is Likely Being Viewed As Another Low-Float Name, Has ~1.4M Shares Outstanding",2018-03-07 14:45:00-05:00,TENX,positive
1220526.0,Tenax Therapeutics Up 7% Over Last Few Mins. As Traders Circulating Takeover Chatter In In Name; Price Has Broken Over $8 Resistance Level Following Chatter,2018-03-07 14:44:00-05:00,TENX,negative
1220527.0,28 Stocks Moving In Monday's Mid-Day Session,2018-03-05 12:32:00-05:00,TENX,neutral
1220528.0,25 Stocks Moving In Monday's Pre-Market Session,2018-03-05 08:02:00-05:00,TENX,neutral
1220529.0,42 Biggest Movers From Friday,2018-03-05 05:08:00-05:00,TENX,neutral
1220530.0,32 Stocks Moving In Friday's Mid-Day Session,2018-03-02 12:20:00-05:00,TENX,neutral
1220531.0,45 Biggest Movers From Yesterday,2018-03-02 05:03:00-05:00,TENX,neutral
1220532.0,Mid-Afternoon Market Update: Dow Falls Over 300 Points; AxoGen Shares Spike Higher,2018-03-01 14:31:00-05:00,TENX,positive
1220533.0,Tenax Therapeutics Shares Up 115% After Co. Earlier Reported Publication Of Preclinical Data Showing Added Evidence Of Levosimendan Treatment Effects In Pulmonary Hypertension,2018-03-01 14:04:00-05:00,TENX,positive
1220534.0,34 Stocks Moving In Thursday's Mid-Day Session,2018-03-01 12:43:00-05:00,TENX,neutral
1220535.0,Mid-Day Market Update: U.S. Stocks Turn Lower; Novavax Shares Gain On Positive Data,2018-03-01 12:21:00-05:00,TENX,positive
1220536.0,"Tenax Therapeutics Shares Halted On Second Circuit Breaker Of Session, Now Up 37%; BZ NOTE: Stock Has Traded ~144K Shares Already This Morning, vs Average Full-Day Volume Of ~25K Shares",2018-03-01 10:27:00-05:00,TENX,positive
1220537.0,"Tenax Therapeutics Shares Spike Into Positive Territory, Now Up 6.5%; Halted On Circuit Breaker",2018-03-01 10:03:00-05:00,TENX,positive
1220538.0,UPDATE: Tenax Says 'Preclinical studies find levosimendan improves right heart function',2018-03-01 08:46:00-05:00,TENX,positive
1220539.0,Tenax Therapeutics Reports Publication Of Preclinical Data Showing Added Evidence Of Levosimendan Treatment Effects In Pulmonary Hypertension,2018-03-01 08:45:00-05:00,TENX,neutral
1220540.0,"Shares Of Penny Stock Tenax Therapeutics Down 23.5% As Co. Announced 1-For-20 Reverse Split Effective Mon., Feb. 26",2018-02-23 13:17:00-05:00,TENX,positive
1220541.0,"Tenax Therapeutics Reports 1-For-20 Reverse Split Effective Mon., Feb. 26",2018-02-23 08:00:00-05:00,TENX,positive
1220542.0,"Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication, There are Currently No FDA Approved Therapies",2018-01-16 07:46:00-05:00,TENX,positive
1220543.0,Ladenburg Thalmann Upgrades Tenax Therapeutics to Buy,2017-05-18 07:27:00-04:00,TENX,neutral
1220544.0,Tenax Meets With FDA To Discuss Positive Mortality Data And Potential NDA Submission For Levosimendan,2017-05-16 16:34:00-04:00,TENX,positive
1220545.0,Volume Spike in Tenax Therapeutics,2017-04-27 11:18:00-04:00,TENX,neutral
1220546.0,"UPDATE: Tenax Therapeutics CEO John Kelley Resigns, Michael Jebsen Named Interim CEO",2017-04-05 17:31:00-04:00,TENX,negative
1220547.0,Tenax Therapeutics Reports Review of Strategic Alternatives,2017-04-05 17:30:00-04:00,TENX,neutral
1220548.0,"Tenax Therapeutics 2016 EPS $(1.56) vs $(0.30) Est, May Not Compare",2017-03-21 06:05:00-04:00,TENX,neutral
1220549.0,Mid-Afternoon Market Update: Under Armour Drops On Earnings Miss; Jaguar Animal Health Shares Climb,2017-01-31 14:31:00-05:00,TENX,positive
1220550.0,18 Biggest Mid-Day Losers For Tuesday,2017-01-31 12:43:00-05:00,TENX,negative
1220551.0,Mid-Day Market Update: Dow Falls Over 100 Points; DryShips Shares Spike Higher,2017-01-31 12:08:00-05:00,TENX,positive
1220552.0,"Tenax Therapeutics Announces Top-Line Results From Phase 3 LEVO-CTS Trial in Cardiac Surgery, Did Not Achieve Primary Endpoints, Met 2 Secondary Endpoints",2017-01-31 09:01:00-05:00,TENX,neutral
1220553.0,7 Biotech Catalysts Remaining In January,2017-01-13 14:08:00-05:00,TENX,neutral
1220554.0,Option Alert: Tenax Therapeutics Feb $5 Call; 4000 @Bid @$0.50; Ref= $2.04,2016-12-28 10:33:00-05:00,TENX,positive
1220555.0,Tenax Therapeutics Reports Closing of Patient Enrollment for Phase 3 LEVO-CTS Trial in Cardiac Surgery; Expects Top-Line Data Readout in Jan. '17,2016-11-18 08:31:00-05:00,TENX,neutral
1220556.0,Tenax Therapeutics Reports Q3 EPS $(0.15) vs $(0.17) Est.,2016-11-10 06:13:00-05:00,TENX,neutral
1220557.0,10 Stocks Which Plummeted Three Days On Increasing Volume,2016-10-20 06:50:00-04:00,TENX,neutral
1220558.0,12 Biggest Mid-Day Losers For Wednesday,2016-10-05 13:13:00-04:00,TENX,negative
1220559.0,UPDATE: Tenax Highlights 'Imperial College data from LeoPARDS trial in septic shock showed treatment arm did not meet primary endpoint; Tenax unlikely to pursue further development for indication',2016-10-05 10:32:00-04:00,TENX,negative
1220560.0,"UPDATE: Tenax Says Phase 3 LEVO-CTS trial in cardiac surgery currently at 833 patients enrolled; total of 880 patients anticipated, with top-line data readout expected near end of 2016",2016-10-05 10:31:00-04:00,TENX,neutral
1220561.0,Tenax Therapeutics Offers Clinical Update for Levosimendan,2016-10-05 10:31:00-04:00,TENX,neutral
1220562.0,Tenax Therapeutics Reports Q2 EPS $(0.17) vs $(0.14) Est.,2016-08-11 06:11:00-04:00,TENX,neutral
1220563.0,Tenax Theraepeutics Q2 EPS ($0.13) vs ($0.10) est,2015-12-15 06:00:00-05:00,TENX,neutral
1220564.0,Tenax Therapeutics Provides Clinical Update for Lead Candidate Levosimendan,2015-10-08 07:30:00-04:00,TENX,neutral
1220565.0,Tenax Therapeutics Q1 EPS -$0.11 vs -$0.14 est,2015-09-14 06:01:00-04:00,TENX,neutral
1220566.0,"Earnings Scheduled For September 14, 2015",2015-09-14 04:04:00-04:00,TENX,neutral
1220567.0,Tenax Therapeutics Reports Q2 Loss $0.50 Vs Prior Loss $2.71,2015-07-16 06:01:00-04:00,TENX,negative
1220568.0,Tenax Therapeutics Shows New Scientific Publication  Regarding the Potential Mortality Benefits of Levosimendan in Septic Shock Patients,2015-06-16 07:07:00-04:00,TENX,neutral
